First experiences screening women at high risk for breast cancer with MR imaging

Breast Cancer Research and Treatment

Volumn 63, Issue 1, 2000, Pages 53-60

  Tilanus Linthorst, Madeleine M A ^a   Obdeijn, Inge Marie M ^a   Bartels, Karina C M ^a   De Koning, Harry J ^b   Oudkerk, Matthijs ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Breast cancer screening; Familial risk; Magnetic resonance imaging

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENE MUTATION; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH CARE COSTS; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHYSICAL EXAMINATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0033788551     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006480106487     Document Type: Article

References (32)

1. Cuurrent policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics
2. Assessment of radiation risk from screening mammography
3. Benefits versus risks from mammography: A critical reassesment
4. Radiation risk of mammography related to benefit in screening programmes: A favourable balance?
5. Second cancer risk following Hodgkins disease: A 20-year follow-up study
6. Breast cancer following treatment for Hodgkins disease: The need for screening in a young population
7. Risk of breast cancer following low-dose radiation exposure
8. Age-specific sensitivities of mammographic screening for breast cancer
9. Breast cancers in women 35 years of age and younger mammographic findings
10. Identification and management of the women at increased risk for breastcancer development
11. Analysis of parenchymal density on mammograms in 1353 women 25-79-year-old
12. Effect of age and breast density on screening mammograms with false-positive findings
13. Occult cancer in women with dense breasts: Detection with screening US diagnostic yield and tumor chracteristics
14. Diagnosis of breast cancer: Contribution of US as an adjunct to mammography
15. Effect of age, breast density, and family history on the sensitivity of first screening mammography
16. Diagnostic accuracy of mammography and contrast-enhanced MR Imaging in 238 histologically verified breast lesions
17. MR imaging of the breast with Gd DTPA: Use and limitations
18. MR lesion detection in a breast cancer population
19. Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions
20. MR imaging guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast
21. MRI in patients with axillary metastases of occult breast carcinoma
22. Autosomal dominant inheritance of autosomal breast cancer
23. Breast Imaging Reporting and Data System
24. Earlier detection of breast cancer by surveillance of women at familial risk
25. MR imaging of the breast in patients with occult primary breast carcinoma Radiology
26. MR depiction of occult breast cancer in patients with malignant axillary adenopathy
27. MR imaging of mammographically detected clustered microcalcifications: Is there any value?
28. Ductal carcinoma in situ: MR Imaging histopathologic correlation
29. Breast cancer diagnosis with MR imaging: Effect of clinical and mammographic findings on recommendations for biopsy
30. Breast cancer screening and cost-effectiveness: Policy alternatives, quality of live considerations and the possible impact of uncertain factors
31. An integrated early detection concept in women with a genetic predisposition for breast cancer
32. Protocol for a nationalmulti-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer